Iya Khalil, Merck VP and head of data, AI and genome sciences (Novartis)

Mer­ck-No­var­tis re­volv­ing door spins again as AI leader Iya Khalil switch­es phar­mas

As talk of AI this-and-that gob­bles up head­line af­ter head­line, one Big Phar­ma is los­ing its AI leader as she tran­si­tions to an­oth­er drug gi­ant: Iya Khalil will trade in her hat as No­var­tis’ go-to ex­pert and leader in the space for Mer­ck as VP and head of da­ta, AI and genome sci­ences next week.

Af­ter near­ly three years lead­ing the ar­ti­fi­cial in­tel­li­gence team at No­var­tis — as Big Phar­ma and biotechs alike latch on­to the ripen­ing AI-for-drug-dis­cov­ery mode of op­er­a­tion — Khalil will switch em­ploy­ers to head up a sim­i­lar post at Mer­ck, where she’ll work out of Cam­bridge, MA be­gin­ning Feb. 13, the com­pa­ny tells End­points News.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.